Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436381 · ClinicalTrials.gov registry record
Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 350
- Enrollment target
NCT03436381: Completed study, sponsored by The Cleveland Clinic.
NCT03436381 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03436381 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
Investigators hypothesize that the obese population (BMI ≥30 kg/m2) who might be at higher risk for obstructive sleep apnea (OSA), carries a higher risk of endoscopy associated adverse events. The primary aim of our study is to determine predictors of endoscopy associated adverse events (airway maneuvers and sedation related complications) in the obese population including the use of the STOP-BANG questionnaire (SBQ) and Epworth Sleepiness Scale (ESS). A secondary aim is to determine the impact of referral to sleep medicine clinic and home sleep test ordered from the gastroenterologist if patient was found to be high risk for OSA by the use of validated questionnaires such as SBQ and ESS.
Primary Outcome
Determine predictors of endoscopy associated adverse events (airway maneuvers and sedation related complications) in the obese population including the use of the STOP-BANG questionnaires and Epworth sleepiness scale
Interventions
- OTHER Questionaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2018-02-09 |
| Est. Completion | 2021-12-18 |
What the finished NCT03436381 record still lists
NCT03436381 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionaire is the first listed.
NCT03436381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03436381 about?
NCT03436381 is a clinical study titled "Can Sleep Apnea Screening Questionnaire Predict Adverse Events in Endoscopic Studies". Investigators hypothesize that the obese population (BMI ≥30 kg/m2) who might be at higher risk for obstructive sleep apnea (OSA), carries a higher risk of endoscopy associated adverse events. The primary aim of our study is to determine predictors of endoscopy associated adverse events (airway mane...
What is the current status of trial NCT03436381?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2018-02-09. Estimated completion is 2021-12-18.
What interventions are being tested in trial NCT03436381?
The interventions under investigation include: Questionaire (OTHER).
Who is sponsoring clinical trial NCT03436381?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI